Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunogenicity of therapeutic proteins.

× No keyword cloud information.

18 in total

1. n-Dodecyl-β-D-maltoside inhibits aggregation of human interferon-β-1b and reduces its immunogenicity.

Authors: Robert A Rifkin; Edward T Maggio; Sonny Dike; Douglas A Kerr; Michael Levy
Journal: J Neuroimmune Pharmacol Date: 2010-06-08 Impact factor: 4.147

Review 2. Fabry disease, enzyme replacement therapy and the significance of antibody responses.

Authors: Patrick B Deegan
Journal: J Inherit Metab Dis Date: 2011-10-25 Impact factor: 4.982

Review 3. Effect of vaccine administration modality on immunogenicity and efficacy.

Authors: Lu Zhang; Wei Wang; Shixia Wang
Journal: Expert Rev Vaccines Date: 2015-08-27 Impact factor: 5.217

Review 4. Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective.

Authors: Anas M Fathallah; Richard B Bankert; Sathy V Balu-Iyer
Journal: AAPS J Date: 2013-07-16 Impact factor: 4.009

5. Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions.

Authors: Austin L Daniels; Theodore W Randolph
Journal: J Pharm Sci Date: 2018-02-01 Impact factor: 3.534

6. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors: Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal: J Pharm Sci Date: 2014-01-22 Impact factor: 3.534

7. Investigation of the immunogenicity of different types of aggregates of a murine monoclonal antibody in mice.

Authors: Angelika J Freitag; Maliheh Shomali; Stylianos Michalakis; Martin Biel; Michael Siedler; Zehra Kaymakcalan; John F Carpenter; Theodore W Randolph; Gerhard Winter; Julia Engert
Journal: Pharm Res Date: 2014-08-15 Impact factor: 4.200

Review 8. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.

Authors: Sujoy Ray; Amita Ray
Journal: Cochrane Database Syst Rev Date: 2016-11-10

9. Effect of route of administration of human recombinant factor VIII on its immunogenicity in Hemophilia A mice.

Authors: Aaron Peng; Puneet Gaitonde; Matthew P Kosloski; Razvan D Miclea; Prashant Varma; Sathy V Balu-Iyer
Journal: J Pharm Sci Date: 2009-12 Impact factor: 3.534

Review 10. Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances.

Authors: Fei Wu; Tuo Jin
Journal: AAPS PharmSciTech Date: 2008-12-16 Impact factor: 3.246